Clinical trial Recruiting at 1 site Interventional Ages 0 Months to 12 Months

Effect of a cleft-adapted bottle with a unidirectional valve on milk intake in infants with cleft palate

Official title: Assessing the Effect of Infant-directed Unidirectional Feeding Valves on Milk Volume Intake in Infants With Cleft Palate- A Randomized Controlled Trial

Run by Phoenix Children's Hospital · NCT07927933 · Data updated 2026-11-12

This study tests whether using a cleft-adapted bottle with a unidirectional valve helps infants with cleft palate take in more milk than a standard bottle.

More Cleft Lip and Palate trials

Quick facts

Study typeInterventional
Ages0 Months to 12 Months
SexAll
Enrollment74 (estimated)
SponsorPhoenix Children's Hospital
Academic / other
Locations1 site (Phoenix, Arizona)
StatusRecruiting
StartedOctober 8, 2026
Main results expectedDecember 31, 2028
Study endsDecember 31, 2029
Registry record updatedNovember 10, 2026
Trial IDNCT07927933 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Infants with diagnosed, unrepaired cleft palate under 12 months gestational age, receiving specific cleft-adapted bottles, and feeding at IDDSI level 0.

Probably not a fit

Infants with submucous cleft palate, receiving tube feeds, or using thickened or non-standard feeds may not benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a cleft-adapted bottle featuring a unidirectional valve to a non-cleft-adapted bottle in infants with unrepaired cleft palate under 12 months old. The goal is to measure oral milk volume intake and milk transfer rate during feeding when using expressed breast milk or standard formulas. Eligible participants are cared for at Phoenix Children’s Hospital and must be using a Dr. Brown’s Zero-Resistance or Pigeon Baby Cleft Palate Bottle and feed at IDDSI level 0. The trial addresses a gap in evidence for feeding devices in cleft-related feeding difficulties, where traditional recommendations are largely based on expert opinion rather than randomized data. Results could inform whether valve-equipped bottles improve feeding efficiency and weight gain potential in this population.

Why it matters

Potential benefit: If successful, infants may experience more efficient milk transfer and better nourishment during feeds.

How similar studies have gone: Historically, evidence for cleft-feeding devices has been limited and based on clinical experience, with some prior studies suggesting ease of use for specialized bottles but few high-quality trials.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Infants with a diagnosed, unrepaired, overt cleft palate under 12 months gestational age cared for at Phoenix Children's, upon receipt of parental/guardian informed consent to participate.
* Infant is using the Dr. Brown's® Zero-Resistance Specialty Feeding System® (Narrow nipple or wide-neck options) or the Pigeon Baby Cleft Palate Bottle
* Infants feeding using milk at IDDSI level 0 (expressed breast milk, commercial formulas, and formula fortified up to 26kcal/ounce)

Exclusion Criteria:

* Infants with a submucous cleft palate.
* Infants receiving supplemental enteral (e.g. "tube") feedings.
* Infants receiving thickened feeds with infant cereal (oatmeal or rice), Gelmix, or pureed food

Where it's running

  • Phoenix Children's Hospital
    Phoenix, Arizona, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.